Citation Impact
Citing Papers
Role of UEV-1, an Inactive Variant of the E2 UbiquitinConjugating Enzymes, in In Vitro Differentiation and Cell Cycle Behavior of HT-29-M6 Intestinal Mucosecretory Cells
1998 StandoutNobel
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1
2007
Identification of a major co-receptor for primary isolates of HIV-1
1996 StandoutNature
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines
2003
Distribution of SIV in Lymph Nodes of Serially Sacrificed Rhesus Monkeys
1995
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
1998
Phylogenesis and Genetic Complexity of the Nonhuman Primate Retroviridae
1994
Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus
1997 StandoutNobel
The ClusPro web server for protein–protein docking
2017 Standout
Generation of CD8 + T Cell-Generated Suppressor Factor and beta -Chemokines by Targeted Iliac Lymph Node Immunization in Rhesus Monkeys Challenged with SHIV-89.6P by the Rectal Route
2000 StandoutNobel
Phylogenetic Analysis of SIV and STLV Type I in Mandrills ( Mandrillus sphinx ): Indications That Intracolony Transmissions Are Predominantly the Result of Male-to-Male Aggressive Contacts
1998 StandoutNobel
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion
1996
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus
1996
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Construction and In Vitro Properties of SIV mac Mutants with Deletions in "Nonessential" Genes
1994
HIV as the cause of AIDS
1996 StandoutNobel
Survey of Simian Immunodeficiency Virus Among Nonhuman Primate Populations
1994
Protection of SIVmac-Infected Macaque Monkeys against Superinfection by a Simian Immunodeficiency Virus Expressing Envelope Glycoproteins of HIV Type 1
1997
Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles
2010
Construction and In Vitro Properties of SIV mac Mutants with Deletions in "Nonessential" Genes
1994
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
1997 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
CHD7 cooperates with PBAF to control multipotent neural crest formation
2010 StandoutNature
Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice
1996
Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus)
1995
Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis
1993
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
A Third-Generation Lentivirus Vector with a Conditional Packaging System
1998 Standout
Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
1996
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Human Rif1 protein binds aberrant telomeres and aligns along anaphase midzone microtubules
2004 StandoutNobel
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.
1994
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
1995
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac
1993
Evidence for Recombination of Live, Attenuated Immunodeficiency Virus Vaccine with Challenge Virus to a More Virulent Strain
2000
Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).
1996
Frequent Substitution Polymorphisms in African Green Monkey CCR5 Cluster at Critical Sites for Infections by Simian Immunodeficiency Virus SIVagm, Implying Ancient Virus-Host Coevolution
2001 StandoutNobel
Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines
1998
Woodchuck hepatitis virus X protein is required for viral infection in vivo
1994
High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys
2000 StandoutNobel
dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions
1997
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2
1997
Persistent infection of macaques with simian-human immunodeficiency viruses
1995
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Interaction of the Human Immunodeficiency Virus Type 1 Vpr Protein with the Nuclear Pore Complex
1998
Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+CD8−CD3+Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7
1999 StandoutNobel
ATM Mediates Cytotoxicity of a Mutant Telomerase RNA in Human Cancer Cells
2008 StandoutNobel
Transport Between the Cell Nucleus and the Cytoplasm
1999 Standout
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B
1995
In Vivo Pathogenesis of a Human Immunodeficiency Virus Type 1 Reporter Virus
1998
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus
1996
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
1995
The Decreased Replicative Capacity of Simian Immunodeficiency Virus SIVmac239ΔnefIs Manifest in Cultures of Immature Dendritic Cells and T Cells
2000 StandoutNobel
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
1998 StandoutNobel
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
Human Immunodeficiency Virus Type 1 Vpr Induces the Degradation of the UNG and SMUG Uracil-DNA Glycosylases
2005
Impact of Viral Factors on Very Early In Vivo Replication Profiles in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys
2005 StandoutNobel
Works of Jonas Müller being referenced
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys
1995
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus
1993